Department of Cellular and Molecular Pharmacology, University of California, San Francisco, 1700 4th Street, San Francisco, California 94158, USA.
Nature. 2010 Feb 25;463(7284):1048-53. doi: 10.1038/nature08787.
Despite the essential roles of sphingolipids both as structural components of membranes and critical signalling molecules, we have a limited understanding of how cells sense and regulate their levels. Here we reveal the function in sphingolipid metabolism of the ORM genes (known as ORMDL genes in humans)-a conserved gene family that includes ORMDL3, which has recently been identified as a potential risk factor for childhood asthma. Starting from an unbiased functional genomic approach in Saccharomyces cerevisiae, we identify Orm proteins as negative regulators of sphingolipid synthesis that form a conserved complex with serine palmitoyltransferase, the first and rate-limiting enzyme in sphingolipid production. We also define a regulatory pathway in which phosphorylation of Orm proteins relieves their inhibitory activity when sphingolipid production is disrupted. Changes in ORM gene expression or mutations to their phosphorylation sites cause dysregulation of sphingolipid metabolism. Our work identifies the Orm proteins as critical mediators of sphingolipid homeostasis and raises the possibility that sphingolipid misregulation contributes to the development of childhood asthma.
尽管神经酰胺脂质作为膜的结构成分和关键信号分子起着重要作用,但我们对细胞如何感知和调节它们的水平知之甚少。在这里,我们揭示了 ORM 基因(在人类中称为 ORMDL 基因)在神经酰胺脂质代谢中的功能——这是一个保守的基因家族,包括最近被确定为儿童哮喘潜在风险因素的 ORMDL3。我们从酿酒酵母的无偏功能基因组方法开始,鉴定出 Orm 蛋白是神经酰胺合成的负调节剂,它们与丝氨酸棕榈酰转移酶形成一个保守的复合物,丝氨酸棕榈酰转移酶是神经酰胺产生的第一步和限速酶。我们还定义了一个调控途径,当神经酰胺合成受到干扰时,Orm 蛋白的磷酸化会解除其抑制活性。ORM 基因表达的变化或其磷酸化位点的突变导致神经酰胺代谢失调。我们的工作确定了 Orm 蛋白是神经酰胺稳态的关键介质,并提出了神经酰胺失调可能导致儿童哮喘发展的可能性。